0HS8:LSE:LSE-Caladrius Biosciences Inc. (USD)

COMMON STOCK | |

Last Closing

USD 3.849

Change

-0.08 (-1.93)%

Market Cap

N/A

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
0R2F:LSE Wells Fargo & Company

-0.26 (-0.35%)

USD 9,223,372,036.85B
0R2T:LSE Micron Technology Inc

+5.42 (+5.41%)

USD 9,223,372,036.85B
0R15:LSE SoftBank Group Corp.

+198.73 (+2.14%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0M69:LSE OTP Bank Nyrt

N/A

USD 5,014.80B
0R28:LSE Newmont Corp.

-0.29 (-0.75%)

USD 4,231.43B
0R2O:LSE Freeport-McMoRan Inc.

-0.03 (-0.08%)

USD 4,154.37B
0QY4:LSE Las Vegas Sands Corp.

-1.55 (-3.04%)

USD 4,148.69B
0QYD:LSE Yum! Brands Inc.

-2.30 (-1.74%)

USD 4,109.92B
0QZ4:LSE Delta Air Lines Inc.

+1.12 (+1.86%)

USD 4,094.73B

ETFs Containing 0HS8:LSE

EATZ AdvisorShares Restaurant .. 5.34 % 0.00 %

-0.43 (-1.51%)

USD 3.47M
HAU-U:CA 3.45 % 0.00 %

N/A

N/A
RCD Invesco S&P 500® Equal W.. 2.34 % 0.40 %

-0.13 (-1.51%)

N/A
SDOG ALPS Sector Dividend Dogs.. 2.31 % 0.40 %

-0.08 (-1.51%)

USD 1.18B
BTAL AGFiQ U.S. Market Neutral.. 0.43 % 0.00 %

+0.27 (+-1.51%)

N/A
RSP Invesco S&P 500® Equal W.. 0.23 % 0.20 %

-0.59 (-1.51%)

N/A
XDEW:LSE Xtrackers S&P 500 Equal W.. 0.23 % 0.00 %

-0.70 (-1.51%)

N/A
XDWE:LSE Xtrackers (IE) Public Lim.. 0.23 % 0.00 %

-29.50 (-1.51%)

N/A
RXI iShares Global Consumer D.. 0.00 % 0.46 %

-1.74 (-1.51%)

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 35.10% N/A N/A 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 35.10% N/A N/A 100% F
Trailing 12 Months  
Capital Gain 32.72% N/A N/A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.72% N/A N/A 87% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 115.00% N/A N/A 95% A
Dividend Return 115.00% N/A N/A 95% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 208.32% N/A N/A 10% F
Risk Adjusted Return 55.20% N/A N/A 73% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike